The future of compression therapy
The World Congress will look at the compression therapy of tomorrow and at the role played by the patient in its success.
Compression therapy is part of the basic therapy for lymphoedema and of conservative therapy for venous diseases. Since lymphoedemas are not curable, it is often hard for the patient to carry out the therapy in the long-term. Mostly the outcome of such therapy is correspondingly deficient. According to Dr Anya Miller, specialist in dermatology, it is all the more important to educate the patient in self-management. Suggestions for this purpose were set out last year in the Guidelines of the Working Party of the Associations for Medical Science (AWMF) on Lymphoedema. To improve treatment adherence, she says, it is helpful to explain the functions of the lymph system, the effect of the individual components of treatment, and the consequences of non-adherence to treatment. What this can look like in practice will be explained by Dr Anya Miller in a symposium entitled “The future of compression therapy.” Chaired by Dr Casper Grim from the Osnabrück Hospital, it will also consider compression in everyday German practice and the current state of operative lymphology and its influence on compression. Next the symposium will take a look at the future development of compression therapy.
The satellite symposium will be held on 16 May from 4.45 to 6.00 p.m. in Room 4 of the OTWorld Congress Center (CCO).